• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

NOZAKI Yumi  野崎 由美

ORCIDConnect your ORCID iD *help
Researcher Number 80530104
Other IDs
Affiliation (based on the past Project Information) *help 2014 – 2017: 山梨大学, 総合研究部, 助教
2012 – 2013: 山梨大学, 医学部附属病院, 助教
Review Section/Research Field
Except Principal Investigator
Hematology
Keywords
Except Principal Investigator
骨髄増殖性腫瘍 / JAK2V617F / MCT / 乳酸 / 骨髄線維化 / 低酸素 / 活性酸素 / 糖代謝 / Lysyl oxidase / ERストレス … More / 線維化 / PP2A / lysyl oxidase / metformin / myelofibrosis / 白血病 / TETファミリー / エピゲノム / JAK2変異 / 低酸素応答 / methylation / WNT5 / Hypoxia / Wnt5 / TET2 / hypoxia Less
  • Research Projects

    (2 results)
  • Research Products

    (4 results)
  • Co-Researchers

    (4 People)
  •  Role of glucose metabolism in development of myelofibrosis

    • Principal Investigator
      KIRITO Keita
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Hematology
    • Research Institution
      University of Yamanashi
  •  Hypoxia modulate epigenomic response in MPN cells

    • Principal Investigator
      KIRITO Keita
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Hematology
    • Research Institution
      University of Yamanashi

All 2015 2014 2013

All Journal Article

  • [Journal Article] Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells2015

    • Author(s)
      Kawashima, I. Mitsumori, T. Nozaki, Y. Yamamoto, T. Shobu-Sueki, Y. Nakajima, K. Kirito, K.
    • Journal Title

      Exp Hematol

      Volume: in press Issue: 7 Pages: 524-533.e1

    • DOI

      10.1016/j.exphem.2015.03.005

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-24591386, KAKENHI-PROJECT-15K09470
  • [Journal Article] Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells2014

    • Author(s)
      Mitsumori, T. Nozaki, Y. Kawashima, I. Yamamoto, T. Shobu, Y. Nakajima, K. Morishita, S. Komatsu, N. Kirito, K.
    • Journal Title

      Exp Hematol

      Volume: 42 Issue: 9 Pages: 783-792.e1

    • DOI

      10.1016/j.exphem.2014.05.007

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-24591386
  • [Journal Article] Anaplastic large cell lymphoma with paraneoplastic neutrophilia: an association between IL-17 elevation and aggressive disease progression.2014

    • Author(s)
      Sueki Y, Nozaki Y, Kawashima I, Yamamoto T, Nakajima K, Mitumori T, Kirito K.
    • Journal Title

      Int J Hematol

      Volume: in press

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591386
  • [Journal Article] Rituximab activates Syk and AKT in CD20-positive B-cell lymphoma cells dependent on cell membrane cholesterol levels2013

    • Author(s)
      Nozaki, Y. Mitumori, T. Yamamoto, T. Kawashima, I. Shobu, Y. Hamanaka, S. Nakajima, K. Komatsu, N. Kirito, K.
    • Journal Title

      Experimental Hematology

      Volume: in press

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591386
  • 1.  KIRITO Keita (90306150)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 4 results
  • 2.  MITSUMORI Toru (80377514)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 3.  NAKAJIMA Kei (20447709)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 4 results
  • 4.  川島 一郎 (20622369)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi